Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence.

Dimosiari, Athina; Patoulias, Dimitrios; Kitas, George D; Dimitroulas, Theodoros

Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence.

Dimosiari, Athina; Patoulias, Dimitrios; Kitas, George D; Dimitroulas, Theodoros.

Afiliación

Dimosiari A; Second Department of Internal Medicine, European Interbalkan Medical Center, 57001 Thessaloniki, Greece.
Patoulias D; Second Department of Internal Medicine, European Interbalkan Medical Center, 57001 Thessaloniki, Greece.
Kitas GD; Outpatient Department of Cardiometabolic Medicine, Second Department of Cardiology, General Hospital Hippokration, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
Dimitroulas T; Department of Rheumatology, Russells Hall Hospital, Dudley Group NHS Foundation Trust, Dudley DY1 2HQ, UK.

J Clin Med ; 12(4)2023 Feb 06.

Article en En | MEDLINE | ID: mdl-36835838

Palabras clave

anakinra; canakinumab; cardiovascular disease; interleukin-1; interleukin-6; tocilizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: J Clin Med Año: 2023 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google